• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Medtronic paying DOJ $9.2M to settle restaurant kickback allegations

Medtronic paying DOJ $9.2M to settle restaurant kickback allegations

October 30, 2020 By Sean Whooley

Medtronic logo updatedThe U.S. Justice Dept. (DOJ) announced that Medtronic (NYSE:MDT) will pay a total of about $9.2 million to settle improper payment allegations.

Fridley, Minn.-based Medtronic agreed to pay $8.1 million to resolve allegations of False Claims Act violations regarding kickbacks for a South Dakota neurosurgeon, along with an additional $1.11 million related to allegations of Open Payments Program violations after the company allegedly failed to accurately report payments to the neurosurgeon to CMS.

“Kickbacks undermine the integrity of federal healthcare programs and increase costs borne by taxpayers,” DOJ Civil Division Acting Assistant Attorney General Jeffrey Bossert Clark said in a news release.  “This case demonstrates [DOJ’s] commitment to ensure that medical device manufacturers do not use improper financial relationships to influence physician decision-making.”

The settlement resolves the allegations that Medtronic agreed to the requests of South Dakota neurosurgeon Dr. Wilson Asfora for the company to pay for social events at the Carnaval Brazilian Grill, a restaurant the company knew Asfora owned, in payments which included many expensive meals.

DOJ alleges that Medtronic made payments to benefit Asfora and induce him to use Medtronic’s SynchroMed II implantable intrathecal infusion pumps for delivering medication to patients. DOJ said the sponsored events at Asfora’s restaurant represented social gatherings for which the surgeon selected and invited social acquaintances, business partners, favored colleagues and potential and existing referral sources, for all of whom Medtronic allegedly paid.

According to the DOJ release, Medtronic allegedly paid for more than 100 events at Asfora’s restaurant over a nine-year period.

The settlement resolves Medtronic’s liability under CMS’ Open Payments Program as part of the Affordable Care Act, requiring medical device manufacturers to disclose certain payments to physicians like Asfora to CMS. DOJ alleged that the company made payments to Asfora’s restaurant at his request, knowing he owned it, but underreported the payments to CMS.

Asfora and two of his other companies are defendants in a separate FCA lawsuit in which the U.S. alleges that he received kickbacks to use certain implants in his spinal surgeries. That case is still pending.

As part of the settlement, Medtronic agreed to cooperate with DOJ’s investigations of and litigation against other partners. The company also took remedial action once it learned of wrongdoing, including terminating a sales representative and sales manager and disciplining 12 other employees involved in the alleged misconduct, DOJ said.

Given that the claims resolved by the settlement remain allegations only, there was no determination of liability.

“Medtronic has reached an agreement to settle civil claims with the Department of Justice in connection with the actions of a small number of sales personnel,” a Medtronic spokesperson told MassDevice via email. “The company will make a payment of $9.2 million to resolve the matter. Outside of a small number of sales employees, DOJ’s investigation did not find that Medtronic was aware of this alleged misconduct at the time it occurred. Upon investigation of this conduct, which violated the company’s policies, Medtronic took various remedial steps, including termination and other disciplinary action against employees directly or peripherally involved, and enhancing relevant training. The settlement agreement contains no admission of liability. Medtronic remains committed to maintaining the highest standards of ethical conduct and compliance with all applicable regulatory guidelines.”

Filed Under: Business/Financial News, Featured, Legal News, Neurological Tagged With: Medtronic, U.S. Justice Dept. (DOJ)

More recent news

  • Aurora Spine begins first procedures with Aero lumbar fusion system
  • Caranx Medical surgical robot TaviPilot AI software wins FDA clearance
  • InspireMD launches carotid stent in U.S. after FDA approval
  • Neuros Medical raises $56M Series D to support nerve stim tech
  • CorWave reports first-in-human LVAD implant

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy